Purpose Of Review: Polymorphous low-grade adenocarcinoma is an entity described in 1984. An increasing number of reports in the pathology literature since then have identified this as the second or the third most common minor salivary gland malignancy. The natural history of polymorphous low-grade adenocarcinoma is distinct from other malignant salivary tumours. The present review will identify the diagnostic difficulties, the treatment options and the treatment outcome of this tumour.
Recent Findings: Polymorphous low-grade adenocarcinoma is a slow-growing tumour that is locally invasive. The most common presentation is that of a lump in the oral cavity, usually on the palate. Diagnosis is established after a biopsy because cytological studies are not helpful. The morphological features can resemble pleomorphic adenoma and adenoid cystic carcinoma. Therapy is primarily wide surgical resection. The role of radiation therapy is not clear in the management of polymorphous low-grade adenocarcinoma. Metastases are rare and recurrences tend to occur more than 5 years after treatment, underlining the need for long-term follow-up. Recurrences can be successfully salvaged in more than 50% of the cases.
Summary: Polymorphous low-grade adenocarcinoma is primarily a pathologic diagnosis. Surgical resection is the mainstay of treatment. Long-term follow-up of 10 years or more is essential to ensure local control.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MOO.0b013e3282f70441 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A rare case of an aggressive polymorphous adenocarcinoma of minor salivary gland in the retro-maxilla.
J Oral Maxillofac Pathol
October 2024
Department of Oral and Maxillofacial Surgery, Manipal College of Dental Sciences, Manipal Academy of Higher Education, Manipal, India.
Polymorphous adenocarcinoma (PAC) is a low-grade malignant tumour of minor salivary glands of the oral cavity, which rarely presents with invasive features. Low metastatic and excellent survival rates are some of its favorable features. A 36-year-old woman reported with swelling, pain, and mobility of teeth in the left upper inner cheek region.
View Article and Find Full Text PDFCase report: Polymorphous low-grade neuroepithelial tumor of the young and supratentorial ependymoma diagnosed in an adult male.
Front Neurol
November 2024
Division of Neurology, McMaster University, Hamilton, ON, Canada.
Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a rare central nervous system (CNS) pathology predominantly observed in the pediatric population. Ependymomas also exhibit a peak incidence in early childhood, with rare presentations after early adulthood. In this report, we describe a rare case of a 41-year-old man diagnosed sequentially with a polymorphous low-grade neuroepithelial tumor of the young, followed by a supratentorial ependymoma within a year.
View Article and Find Full Text PDFPhenotypic and epigenetic heterogeneity in FGFR2-fused glial and glioneuronal tumours.
Neuropathol Appl Neurobiol
December 2024
Neuroradiological RENOCLIP-LOC network: A. Bani-Sadr (Lyon), J.M. Constans (Amiens), D. Galanaud (Paris), R. Guillevin (Poitiers), N. Menjot (Montpellier), S. Grand (Grenoble), F.D. Ardelier (Strasbourg), E. Schmitt (Nancy), B. Testud (Marseille), L. Mondot (Nice).
Aims: FGFR-fused central nervous system (CNS) tumours are rare and are usually within the glioneuronal and neuronal tumours or the paediatric-type diffuse low-grade glioma spectrum. Among this spectrum, FGFR2 fusion has been documented in tumours classified by DNA-methylation profiling as polymorphous low-grade neuroepithelial tumours of the young (PLNTY), a recently described tumour type. However, FGFR2 fusions have also been reported in glioneuronal tumours, highlighting the overlapping diagnostic criteria and challenges.
View Article and Find Full Text PDF[Clinicopathological and molecular characteristics of microsecretory adenocarcinoma in salivary gland].
Zhonghua Bing Li Xue Za Zhi
October 2024
Department of Oral Pathology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shanghai 200011, China.
To investigate the clinicopathological, immunohistochemical, and molecular genetic characteristics of microsecretory adenocarcinoma (MSA) of the salivary gland, and to improve the understanding of this rare tumor. Cases originally diagnosed as MSA at the Department of Oral Pathology, the Ninth People's Hospital of Shanghai Jiao Tong University School of Medicine were retrospectively collected. The cases of polymorphous adenocarcinoma and adenocarcinoma, not otherwise specified from January 2000 to January 2020 were reviewed to identify potential misdiagnosed MSA cases.
View Article and Find Full Text PDFMAPK pathway alterations in polymorphous low-grade neuroepithelial tumor of the young: diagnostic considerations.
Brain Tumor Pathol
October 2024
Department of Neuropathology, National Institute of Mental Health and Neurosciences, Bangalore, India.
Article Synopsis
- - Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a new type of brain tumor mainly affecting children, characterized by specific imaging and histological features, often presenting with seizures.
- - In a study of 15 diagnosed cases, imaging revealed well-defined solid-cystic tumors with calcifications, and histopathology showed a mix of tumor cell types that were immunopositive for CD34.
- - Molecular analysis detected mutations consistent with PLNTY, including BRAF and FGFR2/3 gene alterations, indicating it should be considered as a potential diagnosis for similar tumors, particularly in younger patients with seizure histories.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!